- Home
- OKYO vs AFCG Comparison
OKYO vs AFCG Comparison
Compare OKYO & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- AFCG
- Stock Information
- Founded
- OKYO 2007
- AFCG 2020
- Country
- OKYO United Kingdom
- AFCG United States
- Employees
- OKYO N/A
- AFCG N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- AFCG Real Estate Investment Trusts
- Sector
- OKYO Health Care
- AFCG Real Estate
- Exchange
- OKYO Nasdaq
- AFCG Nasdaq
- Market Cap
- OKYO 85.0M
- AFCG 92.9M
- IPO Year
- OKYO 2022
- AFCG 2021
- Fundamental
- Price
- OKYO $2.24
- AFCG $3.80
- Analyst Decision
- OKYO Strong Buy
- AFCG Hold
- Analyst Count
- OKYO 1
- AFCG 5
- Target Price
- OKYO $7.00
- AFCG $8.17
- AVG Volume (30 Days)
- OKYO 112.8K
- AFCG 270.1K
- Earning Date
- OKYO 07-18-2025
- AFCG 11-12-2025
- Dividend Yield
- OKYO N/A
- AFCG 15.87%
- EPS Growth
- OKYO N/A
- AFCG N/A
- EPS
- OKYO N/A
- AFCG N/A
- Revenue
- OKYO N/A
- AFCG $8,721,514.00
- Revenue This Year
- OKYO N/A
- AFCG N/A
- Revenue Next Year
- OKYO N/A
- AFCG $13.92
- P/E Ratio
- OKYO N/A
- AFCG N/A
- Revenue Growth
- OKYO N/A
- AFCG N/A
- 52 Week Low
- OKYO $0.90
- AFCG $3.44
- 52 Week High
- OKYO $3.35
- AFCG $10.50
- Technical
- Relative Strength Index (RSI)
- OKYO 47.57
- AFCG 34.71
- Support Level
- OKYO $1.93
- AFCG $3.69
- Resistance Level
- OKYO $2.19
- AFCG $4.01
- Average True Range (ATR)
- OKYO 0.18
- AFCG 0.16
- MACD
- OKYO 0.02
- AFCG -0.05
- Stochastic Oscillator
- OKYO 45.65
- AFCG 5.36
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.